Hof H, Finger H, Körner L, Milcke L
Zentralbl Bakteriol Orig A. 1975;230(2):210-22.
The single i.p. injection of 2.5 times 10-8 killed B. pertussis cells protected 23 out of a group of 24 NMRI mice (95.8%) against the subsequent intracerebral infection, whilst 13 out of 24 mice (54.2%) survived the intracerebral challenge with virulent B. pertussis cells after prior oral administration of 2.5 times 10-11 killed B. pertussis cells, as demonstrated by the mouse protection test. Similar treatment with non-specific substances, such as egg white and saline, did not result in any increase of resistance. Systemic anaphylactic hypersensitivity to bovine serum albumin could also be achieved, when either both the protein antigen and the B. pertussis vaccine were given by the oral route or when the B. pertussis vaccine was injected intraperitoneally into mice which had received the soluble protein antigen by the oral route. Such effects were not produced at all in the reverse situation, when the B. pertussis vaccine was orally administered in mice, which were given the soluble protein antigen by the intraperitoneal route. After oral inoculation of 6 times 10-11 killed B. pertussis cells neither splenomegaly nor blood lymphocytosis became detectable. It is still unknown, in which manner the orally administered B. pertussis vaccine effects protection against the intracerebral infection with virulent bacteria as well as susceptibility for systemic anaphylaxis. The data presented do not favor the view that those effects are due to the phenomenon of persorption.
单次腹腔注射2.5×10⁻⁸个灭活百日咳博德特氏菌细胞,可使24只NMRI小鼠中的23只(95.8%)免受随后的脑内感染;而在预先口服2.5×10⁻¹¹个灭活百日咳博德特氏菌细胞后,24只小鼠中有13只(54.2%)在接受有毒力的百日咳博德特氏菌细胞脑内攻击后存活,小鼠保护试验证明了这一点。用非特异性物质如蛋清和生理盐水进行类似处理,并未导致抵抗力增加。当蛋白质抗原和百日咳疫苗均通过口服途径给予,或当百日咳疫苗腹腔注射到已通过口服途径接受可溶性蛋白质抗原的小鼠体内时,也可实现对牛血清白蛋白的全身性过敏超敏反应。当百日咳疫苗口服给予小鼠,而可溶性蛋白质抗原通过腹腔途径给予时,在相反的情况下根本不会产生这种效果。口服接种6×10⁻¹¹个灭活百日咳博德特氏菌细胞后,未检测到脾肿大和血液淋巴细胞增多。口服的百日咳疫苗如何影响对有毒力细菌脑内感染的保护作用以及全身性过敏反应的易感性,目前仍不清楚。所呈现的数据不支持这些作用是由于吸收现象的观点。